welcome to
play

WELCOME TO FLAGSHIP BIOTECH INTERNATIONAL PVT LTD . FLAGSHIP - PowerPoint PPT Presentation

Nov 19, 2023 •325 likes •584 views

WELCOME TO FLAGSHIP BIOTECH INTERNATIONAL PVT LTD . FLAGSHIP BIOTECH INTERNATIONAL PVT. LTD An INDO US An INDO US PHARMA PHARMA PHENOMENON PHENOMENON 2 FLAGSHIP BIOTECH INTERNATIONAL COMPANY PROFILE FLAGSHIP BIOTECH

  1. WELCOME TO FLAGSHIP BIOTECH INTERNATIONAL PVT LTD .

  2. FLAGSHIP BIOTECH INTERNATIONAL PVT. LTD An INDO – US An INDO – US PHARMA PHARMA PHENOMENON PHENOMENON 2 FLAGSHIP BIOTECH INTERNATIONAL

  3. COMPANY PROFILE • FLAGSHIP BIOTECH INTERNATIONAL PVT. LTD . is fully integrated Pharmaceutical company with an established Marketing Network across the globe in 75 countries. • Established in 2009 • Headquarter office in Navi-Mumbai • Branch offices in western India & Global Subsidiary offices in USA & Mexico • More than 700 pharmaceutical Formulations • Operates in more than 75 countries worldwide having more than 400 products registered. • Achieved a Marketing excellence in the Branded Generics - Ethical, API, Formulations, OTC & Institutional segments Globally & has emerged as a respectable name in the Global Pharmaceutical & Healthcare Arena. 3 FLAGSHIP BIOTECH International

  4. Provide quality generics for Emerging markets at affordable prices VISION using Global Standards . Gain leadership positions in Acute & Chronic specialty therapy in MISSION India & other developing nations.  Focus on Quality Product and Customer Satisfaction. VALUES  Applying creative ideas for business improvement and growth opportunities.  Delivering outstanding results + High standards of Performance 4 FLAGSHIP BIOTECH INTERNATIONAL

  5. GROWTH Overview in span of 5 years 237 5 years Projection Turnover 31 159 106 22 71 47 31 14 7 4 2010-2011 2011-2012 2012-2013 2013-2014 2014-2015 Flagship Biotech International Sales revenues Exceeding 31 Crore with a CAGR of 51% over the last five years . 5 FLAGSHIP BIOTECH INTERNATIONAL

  6. Unique Features of company  Flagship is one of the few supplier in India which provides unique, orphan drug hard to find medicine  Growing company in shorter span of time-comparing other company  One of the fastest growing company of Indian Origin in Central American of Caribbean region  In Just short period, Flagship acquired a medium size pharmaceutical company in 2015  Customer satisfaction-with variety of different customers in faster time  In shorter span of time highly penetrated into all export markets  Highly emerged company 6 FLAGSHIP BIOTECH INTERNATIONAL

  7. Our Niche Products: Alprostadil Injection  Dimenhydrinate Injections  Fluphenazone Decanoate Injection  Hydralazine Hydrochloride Injection & Tablet  Indomethacin Injection  Labetalol Injection  L-ornithine L-aspartate Injection  Dextrose Injection  Vasopressin Injection  Atenolol Injection  Benzotropine Injection & Tablet  Milirinone Injection  Nitroglycerine Injection  Octreotide Injection  Protamine Sulphate Injection  Suxamethonium Injection  7 FLAGSHIP BIOTECH INTERNATIONAL Zuclopenthixol Injection  Terlipressin Injection 

  8. Quality – That defines Excellence Innovation, Quality, Service International benchmark - quality and regulatory systems  This objective is achieved by Local & International Rules and  This objective is achieved by Local & International Rules and Regulations applicable to our operations. Regulations applicable to our operations.  Flagship awarded with the ISO 9001: 2008 and with an outstanding  Flagship awarded with the ISO 9001: 2008 and with an outstanding track record for maintaining Quality. track record for maintaining Quality. REGULATORY AFFAIRS  We possess capabilities for preparing, Technical Dossiers and Drug Master Files (DMFs) for  We possess capabilities for preparing, Technical Dossiers and Drug Master Files (DMFs) for a range of our products. a range of our products.  We have registered more than 400 products.  We have registered more than 400 products.  250 CTD Dossiers registered in Asia, Africa, Latin America, CIS , Australia & Pacific Ocean  250 CTD Dossiers registered in Asia, Africa, Latin America, CIS , Australia & Pacific Ocean 8 FLAGSHIP BIOTECH INTERNATIONAL & 215 Products are in Pipeline. & 215 Products are in Pipeline.

  9. Contract Manufact cturing and nd Out lice censing g Service OUR BUSINESS IS SUPPL Y OF YOUR INNOVATIVE PRODUCTS Our Global CMO include :  Reliable supply with products that meet the highest-  Reliable supply with products that meet the highest- quality standards and integrated project management quality standards and integrated project management systems that ensure on-time delivery. systems that ensure on-time delivery.  From Kilogram to Multi-Tons Capabilities.  From Kilogram to Multi-Tons Capabilities.  Cost-effective & customized Manufacturing at our Plant  Cost-effective & customized Manufacturing at our Plant  Complete Regulatory Documentation Support.  Complete Regulatory Documentation Support.  We Seek out-licensing opportunities for our generic  We Seek out-licensing opportunities for our generic formulations for global markets. formulations for global markets. 9 FLAGSHIP BIOTECH INTERNATIONAL  Excellent regulatory track record .  Excellent regulatory track record .

  10. Our Esteemed customer few of them:  Medicuba  Pharmacuba  Ministry of Health Srilanka  Ministry of Health Sychelles  Ministry of Health Dominican Republic  Ministry of Health Guyana  Ministry of Health Trinidad and Tobago  Ministry of Health Bahamas 10 FLAGSHIP BIOTECH INTERNATIONAL

  11. Research and Development Rese sear arch and Development We believe that Research and Innovation are the key success factors for the growth of the company. Our R & D capabilities include : Our R & D capabilities include :  Formulation development for International Markets  Formulation development for International Markets  Dedicated Regulatory Team for global filings  Dedicated Regulatory Team for global filings  Dossier development  Dossier development  Chemical synthesis,  Chemical synthesis,  Process optimization,  Process optimization,  Analytical Development  Analytical Development  Conducting Stability Studies.  Conducting Stability Studies. 11 FLAGSHIP BIOTECH INTERNATIONAL

  12. Global Pr Prese sence ASIA:  MIDDLE EAST – Egypt , Iraq, Iran, Jordan, Lebanon Syria  South East – Afghanistan, Hong Kong, Indonesia, Malaysia, Maldives, Myanmar, Philippines, Srilanka, Taiwan , Vietnam. AFRICA: Angola, Benin, Burkina Faso, Egypt, Ethiopia, Ghana, Kenya, Liberia, Morocco, Mauritius, Madagascar, Mali, Mozambique, Nigeria, Sierra Leone, Senegal, Seychelles, South Africa, Uganda, Zambia, Zimbabwe. LATIN AMERICA - Barbados, Bolivia, Cuba, Costa Rica, Chile ,Dominican Republic, Ecuador ,El Salvador, Guatemala ,Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Peru, Paraguay, Suriname, Trinidad &Tobago, Uruguay, Venezuela. CIS – Belarus, Kazakhstan, Russia, Ukraine. 12 FLAGSHIP BIOTECH INTERNATIONAL AUSTRALIA & PACIFIC OCEAN – Fiji ,New Zealand, Papua New Guiana . Our Global Footprint OF flagship Biotech International in 75 countries

  13. AFRICA Angola, Benin, Burkina Faso, Egypt, CIS Ethiopia, Ghana, Kenya, Liberia, Libya Morocco, Mauritius, Madagascar, Mali, Belarus, Kazakhstan, AUSTRALIA & Mozambique, Nigeria, Sierra Leone, Russia, Ukraine. PACIFIC OCEAN Senegal, Seychelles, South Africa, Uganda, Zambia, Fiji ,New Zealand, Zimbabwe,Namibia,Congo,Equador Papua New Guiana . Global Gl Presen ence LATIN AMERICA ASIA Barbados, Bolivia, Cuba, Costa Rica, Chile ,Dominican Republic,  MIDDLE EAST – Egypt , Iraq, Ecuador ,El Salvador, Guatemala Iran, Jordan, Lebanon Syria ,Guyana, Haiti, Honduras, Jamaica,  South East – Afghanistan, Hong Mexico, Nicaragua, Panama, Peru, Kong, Indonesia, Malaysia, Paraguay, Suriname, Trinidad 13 FLAGSHIP BIOTECH INTERNATIONAL Maldives, Myanmar, Philippines, &Tobago, Uruguay, Venezuela. Srilanka, Taiwan , Vietnam.

  14. Marketing - Broadest Portfolio of high quality of Generic Product ONCOLOGY HORMONES VETERINARY BETA LACTAM ANTIBIOTICS SPECIALITY INJECTABLES NASAL PREPARATIONS EYE & EAR PREPARATIONS GENERAL TABLETS & CAPSULES LARGE VOLUME PARENTERALS 14 FLAGSHIP BIOTECH INTERNATIONAL ACTIVE PHARMACEUTICAL INGREDIENTS

  15. Our Manufacturing site….. 15 FLAGSHIP BIOTECH INTERNATIONAL

  16. Our Plant-Approval & Certificates  IS0 9001  WHO-GMP  cGMP  NAFDAC-Nigeria, Cambodia, Srilanka & Uganda/Kenya in progress . FLAGSHIP BIOTECH INTERNATIONAL

  17. Our plant- (WHO-GMP CERTIFIED COMPANY) we are expert in;  New drugs  Contract manufacturing  Formulation development  New product development  Specialty Products  Injectable  Ophthalmic preparations  Veterinary product  Derma-medicated soap 17 FLAGSHIP BIOTECH INTERNATIONAL

  18. Our Plant Manufacturing capability  Manufacturing of (vials & ampoules)from 1ml to 99 ml  3piece Eye, Ear & Nasal drops  Tubes & bottles  Veterinary Injections 100ml as well FLAGSHIP BIOTECH INTERNATIONAL

  19. Available Dosage form with capacity NO. Dosage form Capacity 1 Ampoules 50,000/shift 2 Vials 50,000/shift 3 Cream and ointment 20,000Tubes/shift 4 Ophthalmic 50,000/day 19 FLAGSHIP BIOTECH INTERNATIONAL

  20. Therapeutic presence  Cardiology  Anti-infective  Pain therapy  Anti-osteoporosis  Anti-asthma  Antimalarial  Veterinary  Derma-medicated soap/cream/ointment/lotion 20 FLAGSHIP BIOTECH INTERNATIONAL

Recommend

More recommend